CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 22 filers reported holding CATALYST BIOSCIENCES INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 253 | +2430.0% | 0.00% | – |
Q1 2023 | $0 | – | 10 | +150.0% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 4 | -99.8% | 0.00% | – |
Q2 2021 | $9,000 | -40.0% | 2,174 | -25.1% | 0.00% | – |
Q1 2021 | $15,000 | +25.0% | 2,902 | +50.1% | 0.00% | – |
Q4 2020 | $12,000 | – | 1,934 | +13714.3% | 0.00% | – |
Q3 2020 | $0 | – | 14 | +366.7% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 3 | -98.7% | 0.00% | – |
Q3 2018 | $2,000 | – | 229 | +22800.0% | 0.00% | – |
Q2 2018 | $0 | – | 1 | -90.9% | 0.00% | – |
Q1 2017 | $0 | – | 11 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 547,541 | $3,214,000 | 6.22% |
ACUTA CAPITAL PARTNERS, LLC | 1,497,900 | $8,793,000 | 2.54% |
22NW, LP | 735,841 | $4,319,000 | 2.34% |
Prosight Management, LP | 248,050 | $1,456,000 | 0.62% |
Worth Venture Partners, LLC | 127,983 | $751,000 | 0.37% |
Parkman Healthcare Partners LLC | 215,237 | $1,263,000 | 0.36% |
Sio Capital Management, LLC | 198,714 | $1,166,000 | 0.34% |
Amtrust Financial Services, Inc. | 50,000 | $294,000 | 0.32% |
Nantahala Capital Management | 1,821,749 | $10,694,000 | 0.32% |
Essex Woodlands Management, Inc. | 78,622 | $462,000 | 0.23% |